Active Pharmaceutical Ingredients Market Size Worth USD 312 Billion by 2028 at 6.2% CAGR, says Market Research Future (MRFR)

Active Pharmaceutical Ingredients Market Size and Trends Analysis By Manufacturing Process, Type of Synthesis, API Formulation, Application, Molecules and Region, Forecast till 2028

Active Pharmaceutical Ingredients Market Overview

The active pharmaceutical ingredient market expected to reach USD 312 Billion by 2028 at 6.2% CAGR, says Market Research Future (MRFR). The expanding drug research and development activities for drug manufacturing, the increased pace of generics, and the increasing consumption of biopharmaceuticals are the primary drivers driving the development of the active pharmaceutical ingredients market. Nevertheless, the market's expansion is likely to be hampered by negative medicine price control regimes in several countries and high manufacturing costs.

The rising frequency of chronic diseases is predicted to boost medicine demand, which will drive the active pharmaceutical ingredients market forward in the coming years. Cardiovascular illnesses are the biggest cause of death worldwide, as per the World Health Organization (WHO), killing an estimated 17.9 million people every year.

Request Free Sample Copy at:

Active Pharmaceutical Ingredients Market Segmentation

The active pharmaceutical ingredients market is segmented based on the manufacturing process: captive manufacturing and contract manufacturing. The application segment is divided into cardiovascular illness, gastrointestinal disorders, neurological disorders, oncology, orthopedic diseases, respiratory disorders, and urology. The market is divided into synthetic and biotech segments based on the kind of synthesis. Based on the size of the molecules, they are classified as big molecules or small molecules.

Active Pharmaceutical Ingredients MarketRegional Classification

The active pharmaceutical ingredients market is divided into four regions: North America, Asia, Europe, and the Rest of the World. North America, Europe, and the Asia Pacific accounted for the greatest proportion of the active pharmaceutical ingredients market in 2019. The growing frequency of preventable chronic diseases, increased government emphasis on generic medications, expanding demand for biologics and speciality drugs, and technological developments in API production methods are all factors contributing to North America's considerable share of the worldwide market.

The European regional active pharmaceutical ingredient market is expected to account for a second major market share during the projection period.

The pharmaceutical active ingredient market in the Asia Pacific is expected to grow at the quickest rate in the worldwide active pharmaceutical ingredient market.

Because of the expanding healthcare infrastructure and rising demand for healthcare products, the Middle Eastern and African active pharmaceutical ingredients market is expected to rise.

Active Pharmaceutical Ingredients MarketKey Players:

The illustrious contenders in the active pharmaceutical ingredient market are Abbott (US), Bayer AG (UK), Merck & Co., Inc (US), Sanofi SA (France), Boehringer Ingelheim GmbH (UK), Novartis AG (UK), and Teva Pharmaceutical Industries Ltd (Israel), GlaxoSmithKline Plc (UK), Hoffmann-La Roche Ltd (Switzerland), Eli Lilly and Company (US), Pfizer Inc. (US).

Industry News

Because of the pandemic, the pulmonology category is currently witnessing a high peak in development, as the pharmaceutical industry is leading the fight against COVID-19 and has addressed this global issue by ensuring the availability of medications despite supply chain disruptions.

The cardiology segment accounts for a major portion of the market due to the large number of people who use various CVD medicines due to the high prevalence of cardiovascular illnesses. Cardiovascular diseases (CVD) remain the largest cause of death and a primary cause of morbidity in Europe, as per the European Society of Cardiology's 2019 statistics. Each year, well over 6 million new cases of CVD are diagnosed in the EU, and more than 11 million in Europe as a whole. The price to the EU economies is substantial, at EUR 210 billion per year, with about 49 million individuals living with the condition in the EU.

Due to the rising frequency of cancer in recent decades, the oncology segment is predicted to grow significantly throughout the forecast period. The disease is anticipated to claim a larger population during the forecast period. Market competitors are constantly developing new APIs to meet the growing demand in the oncology segment worldwide.

Browse Detailed TOC with COVID-19 Impact Analysis at:

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact Info:
Name: Market Research Future
Email: Send Email
Organization: Market Research Future (part of Wantstats Research and Media Private Limited),
Address: 99 Hudson Street, 5Th Floor, New York, New York 10013 United States of America
Phone: +1 628 258 0071

Release ID: 89060856